Medication Guide App

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Health Food Stores Often Promote Adult-Only Supplements to Teens

Health store employees may encourage teens to buy body-shaping dietary supplements, even though the products' labels state they're for adult use only, researchers report. Despite the labeling, it's legal for minors to buy these over-the-counter products in 49 states. However, the American Academy of Pediatrics says teens younger than 18 should not use...

Posted today in Medical

Just 1 Hour of Daily TV Boosts Kids' Obesity Risk, Study Suggests

Watching television, even for just an hour a day, may boost the risk that young children will be overweight or obese, according to new research. "Children who watch one to two hours of TV a day, as opposed to those who watch less, are more likely to be overweight and obese at kindergarten and first grade," said the study's lead author, Dr. Mark DeBoer,...

Posted 2 days ago in New Drug Approvals

FDA Approves Cyramza (Ramucirumab) for Use with FOLFIRI in Second-Line Treatment of Metastatic Colorectal Cancer

Eli Lilly and Company (NYSE: LLY) has received its fourth U.S. Food and Drug Administration (FDA) approval for Cyramza (ramucirumab). Cyramza (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal...

Posted 3 days ago in New Drug Approvals

Medicure Announces Approval of Expanded Dosing Time For Aggrastat

WINNIPEG, April 23, 2015 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, is pleased to announce that the United States Food and Drug Administration (FDA) has approved a revision to the duration of the bolus delivery for the Aggrastat (tirofiban HCl) high-dose bolus (HDB) regimen. The...

Posted 2 days ago in FDA Alerts

Injectable Products by Mylan: Recall - Presence of Particulate Matter

including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot numbers affected by this recall. Some products may be packaged with a Pfizer Injectables label (see Background below)   [Posted 04/24/2015] ISSUE:...

Posted today in Medical

Very Young Kids Often Use Tablets, Smartphones, Study Finds

Up to half of very young children use smartphones and tablets in some way before their first birthday, a new study finds. But parents still worry about their children's use of mobile media, a separate study says. "We were not surprised to find out children were exposed to mobile devices at a young age," said Dr. Hilda Kabali, a pediatric resident at...

Posted today in Medical

More Than 1 in 10 Teens Has Tried E-Cigarettes, Study Finds

American teens' use of electronic cigarettes is growing, especially among those who also smoke tobacco cigarettes, according to a new study. Researchers surveyed more than 10,000 teens across the nation from 2012 to 2014. They found that 22 percent of teens used tobacco cigarettes, 13 percent used water pipes (hookahs), and 10 percent used e-cigarettes...

Posted today in Medical

More U.S. Newborns Enduring Drug Withdrawal: Study

The number of U.S. infants admitted to neonatal intensive care units to treat symptoms of drug withdrawal has nearly quadrupled since 2004, researchers report. Neonatal abstinence syndrome -- a drug-withdrawal syndrome that often occurs after exposure to prescription narcotic painkillers during pregnancy -- affected only seven babies for every 1,000...

Posted 2 days ago in Medical

Health Highlights: April 24, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: FDA Warns Supplement Makers About Stimulant The U.S. Food and Drug Administration on Thursday sent warning letters to the makers of eight dietary supplements that state their products contain a potentially dangerous compound that acts like amphetamine. According...

Posted 2 days ago in Medical

Wider Use of Naloxone Could Cut Deaths From Drug Overdoses: CDC

Allowing more emergency medical service (EMS) workers to administer the prescription drug naloxone could reduce the number of overdose deaths caused by opioid drugs, U.S. health officials said Friday. Opioids include powerful prescription narcotic painkillers such as Vicodin, OxyContin, Percocet and codeine as well as heroin. Prescription opioids caused...

Read more news...

Recently added consumer and prescribing information: Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix, Natpara

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web4)